African Medicinal Plant Substances Could Help Stop Tumor Growth
Johannes Gutenberg University Mainz Experiments using benzophenones derived from plants originating in Cameroon produce evidence that these may be effective against multi-drug resistant cancers African medicinal plants contain chemicals...
Latest Cancer treatments Stories
DUBLIN, June 17, 2013 /PRNewswire/ -- Research and Markets ( http://www.researchandmarkets.com/research/w4l9nk/drug_delivery_in) has announced the addition of Jain PharmaBiotech's new report "Drug Delivery in Cancer - Technologies, Markets and Companies [http://www.researchandmarkets.com/research/w4l9nk/drug_delivery_in ]" to their offering. Drug delivery remains a challenge in management of cancer. Approximately 12.5 million new cases of cancer are being diagnosed...
Published in the Journal for ImmunoTherapy of Cancer, review offers recommendations for manufacturing, pre-clinical studies, and clinical trial designs of cancer immunotherapies Milwaukee, WI (PRWEB) June 14, 2013 A picture of what the FDA is looking for in cancer immunotherapy product development appears in an extensive review article published in the inaugural issue of the Journal for ImmunoTherapy of Cancer. This review outlines a series of recommendations from the FDA, including cited...
New Campaign Raises Awareness of the Importance of the Immune System in Cancer Prevention and Treatment LOS ANGELES and NEW YORK, June 13, 2013 /PRNewswire-USNewswire/ -- Stand Up To Cancer (SU2C) and the Cancer Research Institute (CRI) have teamed up to develop a new print public service announcement featuring NCIS star Mark Harmon. The PSA, entitled "I Am My Own Secret Weapon," is designed to increase awareness about cancer immunotherapy, which mobilizes our immune systems to...
MD Anderson Is The First Site; Other Sites In The US And UK To Follow BETHESDA, Md., June 13, 2013 /PRNewswire/ -- Northwest Biotherapeutics (NASDAQ: NWBO) (NW Bio), a biotechnology company developing non-toxic DCVax(®) personalized immune therapies for solid tumor cancers, announced today that its 60-patient Phase I/II clinical trial of DCVax-Direct for all inoperable solid tumor cancers has been initiated at The University of Texas MD Anderson Cancer Center in Houston,...
Globally Recognized Cancer Treatments Offer A Safer Option For Many Patients. INDIANAPOLIS, June 12, 2013 /PRNewswire/ -- For the first time in the United States, the State of Indiana has approved the opening of a facility that offers Photodynamic Therapy (PDT) and Sonodynamic Therapy (SDT). These therapies use a whole new approach from the traditional "three legged stool" of US cancer therapies of surgery, chemotherapy, and radiation by applying specific light and ultrasound waves...
HINSDALE, Ill., June 12, 2013 /PRNewswire/ -- Wellness House is pleased to announce their annual Chicago suburban symposium, Hot Topics in Breast Cancer, on Saturday June 29. Hot Topics in Breast Cancer 2013 is a free symposium, bringing together top oncologists, surgeons and healthcare professionals in the Chicagoland area to present the latest updates in the treatment of breast cancer. Wellness House welcomes the top doctors and professionals from The University of Chicago...
Research compares standard treatment and addition of targeted therapy with radiolabeled antibodies that track and kill lymphoma cancer cells A new patient protocol for aggressive and recurrent lymphoma that combines intensive chemotherapy and radioimmunotherapy (RIT) may become the most powerful cancer-killing therapy available, with the hope that patients’ lymphoma can be eradicated as they prepare for bone marrow transplant, say researchers at the 2013 Annual Meeting of the Society of...
IndUS will develop and commercialize APS intellectual property to treat oral mucositis, a significant unmet medical need for cancer patients. Mountain View, CA (PRWEB) June 10, 2013 Applied Protein Sciences (APS), a privately held biotech company founded in 2007 in Mountain View, CA, announces that it has been acquired by IndUS Pharmaceuticals (IndUS), a privately held Boston based pharmaceutical company. The acquisition gives IndUS the ability to extend its pipeline to include...
American Chemical Society Scientists are reporting development and successful lab tests on the first potential drug to pack a lethal one-two punch against melanoma skin cancer cells. Hit number one destroys cells in the main tumor, and the second hit blocks the spread of the cancer to other sites in the body, according to their report in the journal ACS Chemical Biology. Nathan Luedtke and colleagues explain that the spread of melanoma and other forms of cancer beyond the original...
STOCKHOLM, June 5, 2013 /PRNewswire/ -- New patents granted in Japan, the USA and Europe SentoClone International AB announced today that it has been granted additional patents in Japan, the US and Europe further reinforcing the global protection of its proprietary SentoClone(R) technology, an active patient specific cellular immunotherapy against cancer based on the ex vivo cultivation and activation of CD4+ T-cells. The technology has advanced to...
